共 31 条
[1]
Multifaceted assessment of the APP/PS1 mouse model for Alzheimer’s disease: Applying MRS, DTI, and ASL[J] . Zhiwei Shen,Jianfeng Lei,Xueyuan Li,Zhanjing Wang,Xinjie Bao,Renzhi Wang.Brain Research . 2018
[3]
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies[J] . Piyoosh Sharma,Pavan Srivastava,Ankit Seth,Prabhash Nath Tripathi,Anupam G. Banerjee,Sushant K. Shrivastava.Progress in Neurobiology . 2018
[4]
Microvascular changes in Down syndrome with Alzheimer-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer’s disease[J] . David A. Drachman,Thomas W. Smith,Bassam Alkamachi,Kevin Kane.Alzheimer’s & Dementia: The Journal of the Alzhei . 2017
[6]
Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer’s disease[J] . Mak Adam Daulatzai.Journal of Neuroscience Research . 2017 (4)
[7]
Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer’s disease[J] . Kimbrough Ian F.,Robel Stefanie,Roberson Erik D.,Sontheimer Harald.Brain . 2015 (12)
[9]
Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success[J] . Haruhiko Sugino,Akihito Watanabe,Naoki Amada,Miho Yamamoto,Yuta Ohgi,Dusan Kostic,Raymond Sanchez.Clinical Therapeutics . 2015 (8)
[10]
The hippocampus in aging and disease: From plasticity to vulnerability[J] . T. Bartsch,P. Wulff.Neuroscience . 2015